Date Posted: May 10, 2019
Application Deadline: Open Until Filled
- University of Miami
- Location: Miami, FL
- Job Number: 7057251 (Ref #: R100031880)
- Posting Date: May 10, 2019
- Application Deadline:
Open Until Filled
The Diabetes Research Institute at the University of Miami, Miller School of Medicine has an exciting opportunity for a Postdoctoral Associate. We are seeking an outstanding candidate interested in immunoengineering research to develop new therapeutics for type-1 diabetes. In specific, the candidate will focus on conducting mechanistic studies in vitro and in vivo to identify the role of chemokine local expression and lymphoid stromal cells in regulating autoimmune responses in murine models of type-1 diabetes. In parallel, the candidate will develop and evaluate in vitro and in vivo hydrogels for local delivery of chemokines and protein/peptide antigens. The ideal applicant should have significant expertise in immunology of autoimmune diseases, cell and molecular biology and experience with murine models of human diseases. Experience in hydrogel biomaterials and in type-1 diabetes will be a plus.
PhD in immunology or pharmacology or biomedical engineering with experience in performing in vitro and in vivo (mice) assays for the measurement of immunological responses and a strong publication record. In-depth expertise in cellular, molecular biology basic techniques, including flow cytometry and hydrogel biomaterials and experience with murine models of human disease. Excellent written and verbal communication skills (English), good interpersonal and organizational skills, orderly laboratory habits and manual dexterity, attention to detail and accuracy, and willingness to work with murine specimens (blood, tissues, cell-lines).
UHealth-University of Miami Health System, South Florida's only university-based health system, provides leading-edge patient care powered by the ground breaking research and medical education at the Miller School of Medicine. As an academic medical center, we are proud to serve South Florida, Latin America and the Caribbean. Our physicians represent more than 100 specialties and sub-specialties, and have more than one million patient encounters each year. Our tradition of excellence has earned worldwide recognition for outstanding teaching, research and patient care. We're the challenge you've been looking for.
Patient safety is a top priority. As a result, during the Influenza ("the flu") season (September through April), the University of Miami School of Medicine requires all employees who provide ongoing services to patients, work in a location (all Hospitals and clinics) where patient care is provided, or work in patient care or clinical care areas, to have an annual influenza vaccination. Failure to meet this requirement will result in rescinding or termination of employment.